Mechanochemistry towards greener pharmaceuticals
Innovative processes to revolutionise how we manufacture drugs and chemicals
The pharmaceutical industry generates tons of toxic waste and carbon emissions. Moreover, it often relies on the supply chains of chemicals and catalysts, which limits timely production during emergencies.
Mechanochemistry gets rid of solvents. It uses mechanical force, like grinding and milling, to drive chemical reactions. It’s succesfully used by other industrial sectors (aerospace, cosmetics, fertilisers…). Now, IMPACTIVE will validate its use in pharma.
An impactful solution
IMPACTIVE is a project funded by the European Commission, which counts on 17 partners in 10 different countries. Our expertise covers the whole value chain, from research to industry and innovation, which will ensure our solutions find ways to market.
Strong industrial collaboration
IMPACTIVE counts with the industry from the start. 2 international companies (Merck & Novartis) are part of the project, to help with the scaling up.
Mashing molecules: an innovative solution towards greener pharmaceuticals
IMPACTIVE is a project funded by Horizon Europe to study the possibilities of mechanochemistry in the synthesis of active pharmaceutical ingredients. This initiative counts on 17 partners in academia and industry, which will work together towards green production processes to increase sustainability and reinforce the European supply chain.
IMPACTIVE holds kick-off meeting in Montpellier
IMPACTIVE held its official kick-off meeting in Montpellier. The project will make mechanochemistry an industrial reality, to reduce the carbon emissions of the pharmaceutical industry.
Our website is live!
IMPACTIVE launches its brand-new website, an online hub to find all the updates about our project, results, and activities